BMC Pulmonary Medicine (Aug 2024)

Predictors of high-flow nasal cannula failure in COVID-19 patients in a northern Peruvian hospital

  • Sara Teresita Calle-Peña,
  • Edwin David Diaz Tavara,
  • Edwin Aguirre-Milachay,
  • Darwin A. León-Figueroa,
  • Mario J. Valladares-Garrido

DOI
https://doi.org/10.1186/s12890-024-03241-0
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Objectives To determine predictors of high-flow nasal cannula (HFNC) failure in COVID-19 patients in a hospital in northern Peru. Methodology A retrospective cohort study was conducted during the months of March and May 2021. Data collection was based on a follow-up of 156 hospitalized patients with a diagnosis of COVID-19 who were users of HFNC. Epidemiological factors and clinical outcomes of treatment were analyzed from medical records. Epidemiological, analytical, and HFNC use-related characteristics were described using measures of absolute and relative frequencies, measures of central tendency, and dispersion. A multivariate Poisson regression analysis with robust variance and a 95% confidence interval was performed. Results We found that age, SpO2/FiO2, work of breathing (WOB scale) at admission, degree of involvement, type of infiltrate on CT scan, lymphocytes, c-reactive protein, and D-dimer were significantly associated with failure of HFNC (p = 60 years [RRa 1.39 (1.05–1.85)] and PaO2/FiO2 score less than 100 [Rra 1.65 (0.99–2.76)]. Conclusions Predictors to failure of HFNC are age older than 60 years and minimally significantly lower PaO2/FiO2 than 100.

Keywords